Tianyu Cai

1.8k total citations
56 papers, 885 citations indexed

About

Tianyu Cai is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Tianyu Cai has authored 56 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Tianyu Cai's work include CAR-T cell therapy research (11 papers), Protein Degradation and Inhibitors (7 papers) and Cutaneous lymphoproliferative disorders research (6 papers). Tianyu Cai is often cited by papers focused on CAR-T cell therapy research (11 papers), Protein Degradation and Inhibitors (7 papers) and Cutaneous lymphoproliferative disorders research (6 papers). Tianyu Cai collaborates with scholars based in China, United States and Japan. Tianyu Cai's co-authors include Marina Konopleva, Naveen Pemmaraju, Shimei Qi, Zhilin Qi, Jie Xing, Qiaojun He, Andrew A. Lane, Chunru Xu, Jason Stephansky and Katsuhiro Togami and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Tianyu Cai

54 papers receiving 879 citations

Peers

Countries citing papers authored by Tianyu Cai

Since Specialization

Citations

This map shows the geographic impact of Tianyu Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyu Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyu Cai more than expected).

Fields of papers citing papers by Tianyu Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianyu Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyu Cai. The network helps show where Tianyu Cai may publish in the future.

Co-authorship network of co-authors of Tianyu Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Tianyu Cai. A scholar is included among the top collaborators of Tianyu Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyu Cai. Tianyu Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Regenerative Microenvironment of the Tissue Engineering for Urethral Strictures 2024 ·Stem Cell Reviews and Reports ·(unknown), Xiaoyu Li, Lei Dong, (unknown), (unknown), Tianyu Cai, Chunru Xu, (unknown), Jian Lin	2
2	Balloon dilation for the treatment of male urethral strictures: a systematic review and meta-analysis 2024 ·BMJ Open ·(unknown), Chunru Xu, (unknown), (unknown), Tianyu Cai, (unknown), Jian Lin	0
3	Targeted screening of the synergistic components in Artemisia annua L. leading to enhanced antiplasmodial potency of artemisinin based on a "top down" PD-PK approach 2023 ·Journal of Ethnopharmacology ·Tianyu Cai, Jianbo Ji, Xin Wang, Jie Xing	2
4	Triple combination targeting methyltransferase, BCL‐2, and PD‐1 facilitates antileukemia responses in acute myeloid leukemia 2022 ·Cancer ·Zhihong Zeng, Abhishek Maiti, Shelley M. Herbrich, Tianyu Cai, Antonio Cavazos, (unknown), Helen Ma, (unknown), Jairo Matthews, Courtney D. DiNardo, Naval Daver, Marina Konopleva	7
5	Calunduloside E inhibits HepG2 cell proliferation and migration via p38/JNK-HMGB1 signalling axis 2021 ·Journal of Pharmacological Sciences ·Shengnan Wang, Xuelei Chen, Jin Cheng, Tianyu Cai, Xiaoming Wu, Zhenyu Cheng, Shimei Qi, Zhilin Qi	21
6	<p>Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma</p> 2020 ·OncoTargets and Therapy ·(unknown), Chunru Xu, (unknown), (unknown), Tianyu Cai, Jian Lin	10
7	Phylogenetic tracing and biological characterization of a novel clade 2.3.2.1 reassortant of H5N6 subtype avian influenza virus in China 2020 ·Transboundary and Emerging Diseases ·(unknown), Min Gu, Tianyu Cai, Kaituo Liu, Ruyi Gao, Dong Liu, Wenqiang Sun, Xiuli Li, Lei Shi, Jiao Liu, Xiaoquan Wang, Jiao Hu, Xiaowen Liu, (unknown), Shunlin Hu, Sujuan Chen, Daxin Peng, Xinan Jiao, Xiufan Liu	7
8	High mobility group box 1 regulates gastric cancer cell proliferation and migration via RAGE-mTOR/ERK feedback loop 2020 ·Journal of Cancer ·(unknown), Shengnan Wang, Tianyu Cai, Zhenyu Cheng, Yu Meng, Shimei Qi, Yao Zhang, Zhilin Qi	16
9	<p>Aloin Inhibits the Proliferation and Migration of Gastric Cancer Cells by Regulating NOX2–ROS-Mediated Pro-Survival Signal Pathways</p> 2020 ·Drug Design Development and Therapy ·Ziqian Wang, (unknown), Shengnan Wang, Tianyu Cai, Tao Hong, Qing Zhang, Shimei Qi, Zhilin Qi	45
10	Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma 2020 ·Journal of Cancer ·(unknown), Anbang He, (unknown), Chunru Xu, Tianyu Cai, Jian Lin	11
11	Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia 2019 ·Molecular Cancer Therapeutics ·Niki M. Zacharias, Natalia Baran, Sriram S. Shanmugavelandy, Jae-Hyuk Lee, (unknown), Prasanta Dutta, Steven W. Millward, Tianyu Cai, Christopher G. Wood, David Piwnica‐Worms, Marina Konopleva, Pratip K. Bhattacharya	22
12	Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN) 2019 ·Blood Cancer Journal ·Hannah C. Beird, Maliha Khan, Rui Wang, Mansour Alfayez, Tianyu Cai, Li Zhao, Joseph D. Khoury, P. Andrew Futreal, Marina Konopleva, Naveen Pemmaraju	24
13	<p>The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1</p> 2019 ·Drug Design Development and Therapy ·Tao Hong, (unknown), Shengnan Wang, Ziqian Wang, Yunfei Ma, Tianyu Cai, (unknown), Shimei Qi, Yao Zhang, Zhilin Qi	23
14	Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells 2019 ·Blood Cancer Journal ·Warren Fiskus, Tianyu Cai, Courtney D. DiNardo, Steven M. Kornblau, Gautam Borthakur, Tapan M. Kadia, Naveen Pemmaraju, Prithviraj Bose, Lucia Masárová, Kimal Rajapakshe, Dimuthu Perera, Cristian Coarfa, Christopher P. Mill, Dyana T. Saenz, (unknown), Baohua Sun, Joseph D. Khoury, Yu Shen, Marina Konopleva, Kapil N. Bhalla	49
15	Liquid chromatography‐tandem mass spectrometry assay for the simultaneous determination of three major flavonoids and their glucuronidated metabolites in rats after oral administration of Artemisia annua L. extract at a therapeutic ultra‐low dose 2019 ·Journal of Separation Science ·Shuqi Wang, Tianyu Cai, Huixiang Liu, (unknown), Jie Xing	11
16	Contribution of Amino Acid Metabolism to Hematologic Malignancies 2018 ·Blood ·Marina Konopleva, Philip L. Lorenzi, (unknown), Yoko Tabe, Tianyu Cai, Stefano Tiziani	1
17	BCL-2 Antagonist ABT-199 Combined with Complex I Inhibitor IACS-010759 Blocks Mitochondrial Respiration and Facilitates Anti-Leukemia Efficacy in Pre-Clinical AML Models 2017 ·Blood ·Qi Zhang, Lina Han, Tianyu Cai, Vinitha M. Kuruvilla, Antonio Cavazos, Helen Ma, Venkata Lokesh Battula, Natalia Baran, Karine G. Harutyunyan, Michael Andreeff, Yoko Tabe, Joseph R. Marszalek, Marina Konopleva	2
18	Investigation of the component in Artemisia annua L. leading to enhanced antiplasmodial potency of artemisinin via regulation of its metabolism 2017 ·Journal of Ethnopharmacology ·Tianyu Cai, (unknown), Jianbo Ji, Jie Xing	26
19	Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax 2016 ·Cancer Discovery ·Joan Montero, Jason Stephansky, Tianyu Cai, Gabriel K. Griffin, Lucía Cabal‐Hierro, Katsuhiro Togami, Leah J. Hogdal, Ilene Galinsky, Elizabeth A. Morgan, Jon C. Aster, Matthew S. Davids, Nicole R. LeBoeuf, Richard M. Stone, Marina Konopleva, Naveen Pemmaraju, (unknown), Andrew A. Lane	144
20	Synergistic Antitumor Activity of Gemcitabine and ABT-737 In Vitro and In Vivo through Disrupting the Interaction of USP9X and Mcl-1 2011 ·Molecular Cancer Therapeutics ·Chong Zhang, Tianyu Cai, Hong Zhu, Liuqing Yang, Hai Jiang, Xiaowu Dong, Yongzhou Hu, Nengming Lin, Qiaojun He, Bo Yang	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact